Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP)

Historical Holders from Q2 2024 to Q3 2025

Symbol
RAPP on Nasdaq
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
47.6M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
49.3M
Holdings value
$1.46B
% of all portfolios
0.004%
Grand Portfolio weight change
+0.001%
Number of holders
123
Number of buys
86
Number of sells
-29
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Third Rock Ventures V, L.P. 19.5% $81.2M 7.14M Third Rock Ventures V, L.P. 31 Dec 2024
Cormorant Asset Management, LP 6.7% $94.8M 3.19M Cormorant Asset Management, LP 30 Sep 2025
Sofinnova Venture Partners XI, L.P. 4.2% $29.2M 1.95M Dr. James I. Healy ("Healy") 11 Sep 2025
JOHNSON & JOHNSON 4.9% $53M 1.78M JOHNSON & JOHNSON 30 Sep 2025

Institutional Holders of Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 49.3M $1.46B +$336M $29.70 123
2025 Q2 38.5M $438M +$4.9M $11.37 81
2025 Q1 38.1M $382M +$11.2M $10.03 77
2024 Q4 36.6M $649M -$29.7K $17.74 69
2024 Q3 28.4M $582M +$37.6M $20.48 55
2024 Q2 25.6M $593M +$593M $23.26 35